Name: Dasatinib monohydrate Content: CAS No.:863127-77-9 Molecular Formula:C22H26ClN7O2S.H2O Structural formula: Formula Weight:506.02 Assay: 99% Appearance: A white powder Usage: API Packing: Following your demands
Main Function:Dasatinib is a cancer drug. Dasatinib is an oral Bcr-Abl tyrosine kinase inhibitor (inhibits the "Philadelphia chromosome") and Src family tyrosine kinase inhibitor approved for first line use in patients with chronic myelogenous leukemia (CML)[1] and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). It is being evaluated for use in numerous other cancers, including advanced prostate cancer.